Authors seldom report the most patient-important outcomes and absolute effect measures in systematic review abstracts.

[1]  G. Guyatt,et al.  Systematic reviews experience major limitations in reporting absolute effects. , 2016, Journal of clinical epidemiology.

[2]  G. Guyatt,et al.  Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients , 2015, BMJ : British Medical Journal.

[3]  G. Guyatt,et al.  Correction: A methodological survey of the analysis, reporting and interpretation of Absolute Risk ReductiOn in systematic revieWs (ARROW): a study protocol , 2013, Systematic Reviews.

[4]  S. Lippmann,et al.  Would You Recognize Fahr's Disease if You Saw It? , 2014, Innovations in clinical neuroscience.

[5]  L. Citrome.  Quantifying clinical relevance. , 2014, Innovations in clinical neuroscience.

[6]  G. Guyatt,et al.  A methodological survey of the analysis, reporting and interpretation of Absolute Risk ReductiOn in systematic revieWs (ARROW): a study protocol , 2013, Systematic Reviews.

[7]  Michael B Gravenor,et al.  Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial , 2013, The Lancet.

[8]  Sally Hopewell,et al.  Incorporation of assessments of risk of bias of primary studies in systematic reviews of randomised trials: a cross-sectional study , 2013, BMJ Open.

[9]  Sally Hopewell,et al.  PRISMA for Abstracts: Reporting Systematic Reviews in Journal and Conference Abstracts , 2013, PLoS medicine.

[10]  M. Marmot.  A probiotic trial: tipping the balance of evidence? , 2013 .

[11]  郭俊男.  Probiotics for the Prevention of Clostridium difficle- Associated Diarrhea: A Systematic Review and Meta-analysisi , 2013 .

[12]  Gordon H Guyatt,et al.  Uncertainties in baseline risk estimates and confidence in treatment effects , 2012, BMJ : British Medical Journal.

[13]  Sam Harper,et al.  Use of relative and absolute effect measures in reporting health inequalities: structured review , 2012, BMJ : British Medical Journal.

[14]  D. Altman,et al.  Reporting of effect direction and size in abstracts of systematic reviews. , 2011, JAMA.

[15]  C. Granger,et al.  High-risk patients with ST-elevation myocardial infarction derive greatest absolute benefit from primary percutaneous coronary intervention: results from the Primary Coronary Angioplasty Trialist versus thrombolysis (PCAT)-2 collaboration. , 2011, American heart journal.

[16]  L. Citrome.  Relative vs. absolute measures of benefit and risk: what’s the difference? , 2010, Acta psychiatrica Scandinavica.

[17]  J. Ioannidis,et al.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration , 2009, BMJ : British Medical Journal.

[18]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.

[19]  W. Johnson,et al.  Interpretation of absolute measures of disease risk in comparative research. , 2007, Family medicine.

[20]  G. Yamey,et al.  The Impact of Open Access upon Public Health , 2006, PLoS Medicine.

[21]  A. Akobeng.  Understanding measures of treatment effect in clinical trials , 2004, Archives of Disease in Childhood.

[22]  A. Dans,et al.  Relative risk reduction , absolute risk reduction and number needed to treat , 2022 .

[23]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.